コンテンツへスキップ
Merck
  • High altitude may alter oxygen availability and renal metabolism in diabetics as measured by hyperpolarized [1-(13)C]pyruvate magnetic resonance imaging.

High altitude may alter oxygen availability and renal metabolism in diabetics as measured by hyperpolarized [1-(13)C]pyruvate magnetic resonance imaging.

Kidney international (2013-12-20)
Christoffer Laustsen, Sara Lycke, Fredrik Palm, Jakob A Østergaard, Bo M Bibby, Rikke Nørregaard, Allan Flyvbjerg, Michael Pedersen, Jan H Ardenkjaer-Larsen
要旨

The kidneys account for about 10% of the whole body oxygen consumption, whereas only 0.5% of the total body mass. It is known that intrarenal hypoxia is present in several diseases associated with development of kidney disease, including diabetes, and when renal blood flow is unaffected. The importance of deranged oxygen metabolism is further supported by deterioration of kidney function in patients with diabetes living at high altitude. Thus, we argue that reduced oxygen availability alters renal energy metabolism. Here, we introduce a novel magnetic resonance imaging (MRI) approach to monitor metabolic changes associated with diabetes and oxygen availability. Streptozotocin diabetic and control rats were given reduced, normal, or increased inspired oxygen in order to alter tissue oxygenation. The effects on kidney oxygen metabolism were studied using hyperpolarized [1-(13)C]pyruvate MRI. Reduced inspired oxygen did not alter renal metabolism in the control group. Reduced oxygen availability in the diabetic kidney altered energy metabolism by increasing lactate and alanine formation by 23% and 34%, respectively, whereas the bicarbonate flux was unchanged. Thus, the increased prevalence and severity of nephropathy in patients with diabetes at high altitudes may originate from the increased sensitivity toward inspired oxygen. This increased lactate production shifts the metabolic routs toward hypoxic pathways.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ストレプトゾシン, ≥75% α-anomer basis, ≥98% (HPLC), powder
Sigma-Aldrich
尿素, powder, BioReagent, Molecular Biology, suitable for cell culture
Sigma-Aldrich
尿素, ACS reagent, 99.0-100.5%
Supelco
Urea, 8 M (after reconstitution with 16 mL high purity water)
Sigma-Aldrich
尿素 溶液, BioUltra, ~8 M in H2O
Sigma-Aldrich
尿素, ReagentPlus®, ≥99.5%, pellets
Sigma-Aldrich
尿素, BioUltra, Molecular Biology, 99% (T)
Sigma-Aldrich
尿素, BioXtra, pH 7.5-9.5 (20 °C, 5 M in H2O)
Sigma-Aldrich
尿素, suitable for electrophoresis
Sigma-Aldrich
尿素, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%, 99.0-101.0% (calc. on dry substance)
Supelco
尿素, analytical standard
Sigma-Aldrich
尿素, meets USP testing specifications
USP
尿素, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
尿素, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99%
Sigma-Aldrich
尿素 溶液, 40 % (w/v) in H2O
Millipore
尿素 溶液, suitable for microbiology, 40% in H2O
尿素, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
尿素, JIS special grade, ≥99.0%
Sigma-Aldrich
Urea-12C, 99.9 atom % 12C
Sigma-Aldrich
尿素, SAJ first grade, ≥98.0%
Sigma-Aldrich
尿素, ≥99.0%